Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transplantation for Aging-related Low-grade Inflammation
NCT06448052Phase 2Active, not recruiting
- Start
- Nov 2023
- Primary completion
- Jan 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in low-grade inflammation, type 2 diabetes mellitus (T2DM), dyslipidemia, obesity. Started Nov 2023; status: active, not recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
low-grade inflammationtype 2 diabetes mellitus (T2DM)dyslipidemiaobesity
Beyond the preview
Go deeper on NCT06448052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448052.